12.42
price up icon19.31%   2.01
after-market Dopo l'orario di chiusura: 12.31 -0.11 -0.89%
loading

Lyell Immunopharma Inc Azioni (LYEL) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
76.92%
0.003
0.013 0.025 0.027 0.065
Operating Expenses
6.62%
55.58
59.52 59.06 65.93 62.62
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
6.62%
55.58
59.52 59.06 65.93 62.62
Operating Income/Loss
6.61%
-55.58
-59.51 -59.04 -65.91 -62.56
Nonoperating Income/Loss
177.41%
-5.092
6.578 8.186 2.015 -4.403
Income/Loss From Continuing Operations Before Tax
76.92%
0.003
0.013 0.025 0.027 0.065
Income/Loss From Continuing Operations After Tax
14.62%
-60.67
-52.93 -50.85 -63.89 -66.96
Net Income/Loss
14.62%
-60.67
-52.93 -50.85 -63.89 -66.96
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
41,856%
254.25
0.606 251.32 250.20 249.59
Diluted Average Shares
41,856%
254.25
0.606 251.32 250.20 249.59
Basic Earnings Per Share
20.00%
-0.24
-0.20 -0.20 -0.26 -0.27
Diluted Earnings Per Share
20.00%
-0.24
-0.20 -0.20 -0.26 -0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):